This three-day course provides a comprehensive introduction to the MATLAB® technical computing environment. No prior programming experience or knowledge of MATLAB is assumed. Themes of data analysis, visualization, modeling, and [….]
This evening workshop is being offered on Tuesday, Aug. 17, Thursday, Aug. 19, Tuesday, Aug 24, Thursday, Aug 26, Tuesday Aug 31 and Thursday, Sep 2 from 6:00PM to 8:30PM. [….]
5 Questions with Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region and beyond to share a little about themselves, their work, and maybe something completely unrelated. This week we welcome Stephanie M. Davis, Ph.D., Program Officer, National Heart, Lung, and Blood Institute. Stay tuned for more interviews with others from across the BioHealth Capital Region and beyond.
We will work in RStudio, an integrated development environment (IDE) built specifically for R. A copy of all the scripts used in class to import and tidy data, create visualizations, [….]
This workshop will be held live on June 1, 8, 15, 2021 (5:30PM-8:00PM) Overview In this workshop, learners will learn the basics of how to use R to wrangle data, [….]
Rockville’s Integrated BioTherapeutics Inc. Awarded $16.3M Contract from the National Institute of Allergy and Infectious Diseases to Develop a Treatment for Marburg Virus Disease
Integrated BioTherapeutics Inc. (IBT), a Maryland biotechnology company specializing in emerging infectious diseases, announced today the receipt of a contract valued at up to $16.3 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop IBT-T03H, a monoclonal antibody for treatment of Marburg virus disease (MVD). MVD is caused by either of two marburgviruses, Marburg virus and Ravn virus, and has reemerged several times since it was initially described in 1967. IBT-T03H, discovered in collaboration with the University of Maryland, has been shown in preclinical studies to be protective against both Marburg and Ravn virus.
The Tumor-Infiltrating Lymphocytes (TIL) Cell Processing Modular Facility is the first large-scale, fully prefabricated and modular multi-module cGMP manufacturing facility of its kind ever built in the United States. The National Cancer Institute (NCI) will utilize the facility to deliver cutting-edge cancer treatment.
Leading coronavirus scientist, Kizzmekia S. Corbett, to join Harvard T.H. Chan School of Public Health to continue vaccine development research
Leading coronavirus scientist Kizzmekia S. Corbett is joining Harvard Chan School as an assistant professor to continue vaccine development research.
The NIH Career Symposium highlights the diversity of career choices available to your generation of biomedical researchers.
This workshop will be held live on April 6, 13, 20, 2021 (5:30PM-8:00PM) OVERVIEW This workshop will explore both the design side and the coding side of creating visualizations in [….]